Changes to the U.S. health care system take effect today. But while the measures will clearly benefit many Americans, the new law’s real price tag is still a subject of fierce disagreement.
Continue reading Hea…
U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.
Contin…
While a new report from Goldman Sachs says health care is in a state of flux that most of the sector’s companies haven’t adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investo…
Sanofi-Aventis, which has been unsuccessful recently in its courtship of U.S. giant biotech Genzyme, announced another setback today. A late-stage trial of NV1FGF did not meet its primary goal of preventing a major amputation o…
After a long wait, the FDA has OK’d Novartis’s Gilenya as a first-line treatment for relapsing forms of multiple sclerosis — the disease’s most common form. MS affects over 400,000 Americans and more than 2.1 million people wo…